Theranostics Australia, the first private theranostics facility in Australia, opened in August 2015, and is based at Diagnostic Nuclear Imaging at Hollywood Private Hospital, Perth, Western Australia. Theranostics Australia is developing targeted molecular diagnostic imaging and therapeutic agents for the diagnosis and treatment of cancers, focusing particularly on cancers which are difficult to treat or are becoming resistant to conventional therapies.
In May 2015 Theranostics Australia was established by Dr Nat Lenzo who wanted to provide patients with contemporary cancer treatment options. Since 1999 he has been involved with treatment of thyroid cancer with radioactive iodine and new agents such as I-131 rituximab for lymphoma treatment and Lu-177 octreotate for neuroendocrine tumour treatment. The company commenced in Perth, Western Australia and the head office is based in Palmyra. The medical facilities are housed in the premises of Diagnostic Nuclear Imaging at Hollywood Private Hospital in Nedlands.
Diagnostic Nuclear Imaging, headed by Dr Joe Cardaci has a long history of involvement in radionuclide therapies. They are one of the pioneers in developing SIRT therapy for metastatic tumours to the liver and provide this service at Hollywood Private Hospital. They are also the first practice in Western Australia to administer Radium-223 for metastatic bone disease from prostate cancer.
To develop and provide powerful and innovative therapies.
To improve quality of life and restore hope.
Courage, Education, Excellence, Hope and Innovation.